The MURANO study: final analysis and retreatment/crossover substudy results of VenR for patients with relapsed/refractory CLL. Kater AP, Harrup R, Kipps TJ, Eichhorst B, et al. Blood 2025;145:2733-2745.

Read + Share

Amedeo Smart

Independent Medical Education

Read + Share

Kater AP, Harrup R, Kipps TJ, Eichhorst B, et al. The MURANO study: final analysis and retreatment/crossover substudy results of VenR for patients with relapsed/refractory CLL. Blood 2025;145:2733-2745.
PMID: 40009494